InvestorsHub Logo
Followers 1
Posts 27
Boards Moderated 0
Alias Born 02/06/2013

Re: None

Tuesday, 11/05/2013 10:01:22 AM

Tuesday, November 05, 2013 10:01:22 AM

Post# of 425377
Management is not incompetent. Like many here I hate looking at my account balance (or lack thereof) since the AdComm but I think we need to keep things in perspective.

First, its my understanding that JZ and some of his top managers were at Reliant which developed Lovaza. As a result, these people know how to bring a drug to market. They also fetched $1.6 BB for the sale of Reliant. We have a better drug here. I am willing to give them some time to right the ship.

Second, many of us (including myself) question the process here and the integrity of the FDA. If we are correct that AMRN was the victim of underhanded dealing - how can we blame management? I don't recall any longs predicting this. Hindsight is 20/20. Again, I'm willing to give management time to regroup.

I will agree that JZ was horrible during the post-AdComm CC and his manner during the past couple of years has been akin to the cat that ate the canary. Depending on his replacement I wouldn't cry too hard if he was sacked. That being said now its time for management to prove its worth but I don't want action for action's sake. I want a well considered plan to get AMRN back where it belongs.

GLTAL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News